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Abstract 
The rapid development of biomedicine demands a trustworthy, proactive regulatory regime 
that is able to manage progress with genuine regard for ethical, social and legal concerns. 
With its recent past of eugenics and euthanasia, Germany is particularly concerned with 
setting up a fair and transparent approach, able to respond quickly to scientific 
developments as well as societal concerns. 
This paper reports on the development, implementation and evaluation of a citizen 
scenario workshop as a tool of participatory prognostics, integrating elements from 
participatory technology assessment and forecasting. In seven days of highly structured 
work and expert support, 24 German participants developed four scenarios on “The 
relationship of biomedicine and the economy in the year 2014”. 
Results and evaluation both show that the process (1) leads to scenarios that provide a 
useful perspective beyond expert opinion; (2) enriches the public and political discourse 
and (3) offers a social learning opportunity appreciated by non-professionals and experts 
alike. We are confident in recommending this technique as a useful addition to existing 
foresight and horizon scanning activities. 
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Introduction 
Biomedicine in Germany 
Human genomics has advanced over recent decades to become one of the fastest 
growing areas in elementary research as well as clinical and industrial application1-3. 
Symbolic scientific milestones such as the mapping of the entire human genome4 or the 
ongoing discovery of the ever-changing potential of stem cells5 have created a fast-
moving, excited societal discourse around future prospects particularly in the areas of 
genetic diagnostics and regenerative medicine. 
At the same time, critical and cautious voices have grown louder pointing towards the 
ethical problematic of embryo research, religious conflicts in pluralistic societies6-8 or 
questioning the desirability of biomedical research altogether9. 
Particularly in Germany, those who take a rather sceptical stance toward the latest 
developments in molecular medicine and biology have a strong position in the political-
legal and public discourse for a number of reasons, including the country’s recent past with 
its record of eugenics and euthanasia10. 
The dilemma of control  
In this volatile environment, anticipating future developments of innovative technologies is 
extremely difficult yet important in order to retain a proactive ability to control and foster 
positive development of research and application, assess potential impacts and limit 
unwanted consequences while still reaping the benefits taking into account justified social, 
ethical and legal concerns11. 
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The complex and paradoxical relationship between technological evolution and its societal 
control is well known as the Collingridge-Dilemma. In its early stages, assessing the 
development and impact of a new technology tends to suffer from fundamental 
uncertainties and ignorance at a scientific-technical level rendering regulation and 
management difficult. The technology’s societal penetration on the other hand, its 
embeddedness in societal discourse and practices, is low. In principle, this enables flexible 
regulation without excessive resource (cost) implications. Scientific technical uncertainty 
decreases as the technology itself and its various applications become better understood. 
In principle, this improves the opportunity for effective and efficient regulation. Yet societal 
penetration progresses in parallel, increasing the cost of regulation and, in reality, often 
hindering the implementation of effective regimes12.  
In trying to deal with this dilemma, managers and regulators traditionally have a number of 
options: 
(1) “Sit and wait”: Carefully monitor developments until the baseline data is 
sufficient to warrant particular action 
(2) “Prognostics”: Use of expert judgement-based forecasting approaches such 
as Delphi13,14 
(3) ”Integrative exploration”: contextual and integrative exploration of a wide 
range of impacts using a broad knowledge and experience base; focus on 
ripple effects, possible interactions, wild carts, etc.15-17 
For biomedical developments that demand proactive political and regulatory action, “sit 
and wait” is often an unrealistic option not least due to legal constraints based on, e.g. a 
duty of care. Hence the following sections will argue the case for “integrative exploration“ 
as an option linking the forward looking approach of prognostics with participatory and 
discursive techniques more akin to participatory technology assessment. 
Technology assessment and political culture 
In the US and Europe, participatory techniques have become increasingly desirable in 
political decision-making over recent years and continue to do so18-20. Germany, however, 
has relied for a long time on elections as a sufficient means of public representation in 
political decision-making and is only now beginning to move towards a wider set of 
methods for public engagement. Compared to some of its European neighbours such as 
Switzerland, with a strong tradition of direct democracy (referenda are unconstitutional in 
Germany at federal level), or Denmark with its history of participatory technology 
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assessment, Germany is a long way away from integrating participatory techniques into its 
political culture. 
Nevertheless, in the context of genomics, the high profile Enquête Commission “Law and 
Ethics in Modern Medicine” of the Deutsche Bundestag (House of Representatives) 
argued in its final report21 that parliament should support  
(1) the democratic public discussion about ethical, legal and social questions in 
modern medicine; 
(2) specifically the public discourse processes that are based on the active 
involvement of citizens and 
(3) policy advice panels that involve the public in an appropriate and especially 
dialogic format. 
 
A range of techniques is available to involve the public in risk and technology 
assessments22-24. Participatory technology assessments, for example, employ focus 
groups, consensus conferences or citizens’ juries and typically aim to elicit participants’ 
attitudes, beliefs and values within a certain context in an attempt to arrive at a more 
comprehensive knowledge base than would be possible using scientific-technical 
knowledge only25-29. They are typically designed as decision support tools for an existing 
decision problem. Rarely do they deal explicitly with possible future developments. 
Participatory prognostics 
Creating and evaluating possible future developments has been the role of forecasting and 
prognostics which have traditionally relied on expert- or stakeholder-based processes. 
Particularly in highly complex areas such as economics and medical science, predictions, 
forecasts and best estimates have been and continue to be developed predominantly by 
those who have a good grasp of the scientific-technical issues as a matter of their 
profession or long-term involvement in a particular field. 
In this context, a tool that has received increasing attention over recent years is the 
scenario method24,30-34. “Scenario analysis is an interactive process engaging a group in a 
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process of identifying key issues, creating and exploring scenarios in order to learn about 
the external environment and/or integrating the insights into the decision-making of [an] 
organisation.”35  
The scenario method was initially conceptualised as a tool to support strategic 
management36,37. Typically, scenario building starts with the current status quo and 
tries to identify driving forces that may influence future developments. Scenarios can 
be built using different assumptions regarding the direction in which these forces may 
act, and a consistent combination of these assumptions for different driving forces38. 
Oftentimes, these scenarios enable the participants to identify possible positive and 
negative consequences for a particular field of reference and to recommend strategic 
action in an attempt to maximise opportunities and avoid or minimise risks. 
Besides their use in current business practice, the method is an integral part of 
technology assessment33, as part of which the scenarios are typically “written” by 
research teams often consulting prognostics, trend extrapolation and modelling39. 
More recently, the technology assessment community has begun to frame the scenario 
method as a communicative process and an instrument to foster societal involvement in 
the debate about possible futures40. However, few practical examples exist. At the 
beginning of the 1990s the European Commission developed the “European Awareness 
Scenarios Workshop” in Denmark and ran this project in different European cities as part 
of the implementation of Agenda 21 initiatives. Important topics were inner city 
rejuvenation and city ecology41. An important element of this approach is the informal 
involvement of societal actors in decisions about local futures. This shift enabled the use of 
the scenario method as a participatory technique. 
In contrast to other participatory techniques, such as, for example, planning cells and 
mediation techniques, scenario processes are not aimed at gauging informed judgements 
about specific planning options or mediating between controversial interests in open 
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conflict. This technique focuses more on developing common visions for possible futures 
on the basis of which to derive options for strategic action. Compared to the future 
conferences and workshops that were developed in the 1960s, the scenario method 
employs highly structured and systematic processes. 
A wealth of different scenario-approaches exists involving qualitative or quantitative data, 
experts, stakeholders or key decision-makers and following an anticipatory or exploratory 
route42. Yet at a fundamental structural level, most share some common elements: 
-------------------------- 
insert figure 1 about here 
-------------------------- 
Note that the scenario panel will not usually involve the general public and that the actual 
scenarios are constructed by the research team following careful analysis of brainstorming 
and deliberations. 
This paper reports on an attempt to develop the scenario method as a means of 
participatory prognostics – a citizen-based method intensively supported by experts. 
Helping citizens to construct their own scenarios was seen as a potentially useful tool in 
the process of creating a wider knowledge base for decision-making processes.  
Method 
Topic & Participants 
The citizen scenario workshop was entitled “The relationship of biomedicine and the 
economy in the year 2014c”. The observation that the ongoing commercialisation of 
biomedicine raises, inter alia, ethical questions that society has to reflect and evaluate 
formed the basis for the process. Rather than directing participants towards a specific set 
of questions and priorities, the scene was left wide open for substantive determination by 
the group and participants were encouraged to think freely about developments that they 
                                              
c 2014: Begin of the 18th German Parliamentary Period  
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thought were desirable, undesirable or even scary. The process did not aim to exclude 
possibilities but fostered the unrestricted exploration of a range of interdependent 
outcomes. The only boundaries to participants’ creativity were established upfront by the 
topic ‘biomedicine and the economy’ and a focus on the current German system as a 
starting point (though within its international context). 
All in all, 34 men and women (10 experts; 24 citizens) from different professions and aged 
18 – 41 participated in the workshop that took place in Germany (Berlin) in the autumn of 
2002. The sampling procedure employed a series of announcements in schools, 
universities and trade associations as well as a number of distribution lists attached to the 
work of the European Youth Parliament in order to oversample young people with a 
political interest and an above average educationd. From the self-selected total sample, 24 
participants were selected so as to give a balanced distribution with respect to gender, age 
and occupation.  
------------------------- 
Insert figure 2 about here 
----------------------- 
We recognise that this clientele is by no means representative of the wider population. Yet 
it represents a group of people that take a particular interest in the subject matter and for 
whom the futures developed in the process are of actual relevance. This was seen as 
beneficial during the infancy stage of this tool’s development. Nevertheless, this kind of 
theoretical sampling has to be acknowledged as a limitation to which further work in this 
area needs to pay attention. 
Though scenarios do not necessarily have to be “realistic”, developing ideas from an 
incorrect or misunderstood factual basis is neither helpful nor a satisfying process. In order 
not to confront and possibly confuse participants with too much information upfront, 
                                              
d All participants had at least finished high school with many currently enrolled in college programmes. 
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participants were sent basic information on biomedical developments, their societal 
relevance and current economic importance. Further factual information was provided by a 
range of expertse from relevant fields that were present in the sessions. This set-up worked 
well as participants initially focused on their own understanding of the topic and only 
consulted external knowledge to answer specific questions that emerged as relevant from 
the discussions. Surprisingly, consultation of experts as experts was fairly limited. Instead, 
they were rapidly included in the discussions on the basis of their personal views rather 
than as experts delivering specific information. 
Structured in seven stages, the entire process lasted seven days and was conducted on 
three different weekends in two main sessions and one subsection meeting. Participants 
were paid expenses only. 
Stage sequence 
The stages were developed from work by Reibnitz43 and are illustrated in figure 3 below. 
---------------------------------- 
insert figure 3 about here 
---------------------------------- 
Stages: 
1. Impact analysis 
In a first step, all those factors were identified that were seen as impacting 
on the role of the economy in biomedical research. In a series of working 
groups focusing on politics, law, science, society and the economy, impact 
factors were collected before participants debated and structured them in a 
plenary session. In order to ensure a common understanding of the 
terminology, a short description of the status quo of each factor was worked 
                                              
e Experts were recruited from Universities covering biology, medicine, economics, social science and ethics. 
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up. As not all factors were seen as equally relevant and influential, a 
weighting at this stage led to the selection of 27 relevant factors. 
2. Interdependence analysis: 
These 27 factors were not perceived as independent of each other. Hence in 
order to gauge the participants’ understanding of these interdependencies, 
all factors were assessed with regards to their impact in a pair-wise 
comparison conducted using a cross-impact-matrix. Using a three point 
scale (0=no influence; 1=little influence; 2=major influence), each participant 
assessed each factor in combination with every other factor and the other 
way around, e.g. what is the impact of the acceptance of biomedical 
products on the freedom of research and vice versa. A majority vote dictated 
the overall group verdict where consensus building through deliberation 
failed. 
3. Grid System (subgroup of five participants) 
Once the different impact levels were assessed for each factor using the 
cross-impact-matrix, they could be placed on a grid system according to 
their active and passive impact, i.e. to what extent does a single factor 
impact on elements of its environment and to what extent is the same factor 
influenced by others? Those factors with high active impact levels were 
chosen to form the building blocks for the scenario development. Twelve 
key factors were selected. 
4. Projections  
Depending on the development of these factors and their interactions, one 
can imagine different paths toward a future. These possible projections were 
developed and described by the participants in detail on the basis of an in-
depth discussion. Key impact factors and their projections formed the basis 
for the scenario development. 
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5. Clustering of Alternatives 
In order to develop internally coherent and plausible scenarios, the 
projections were intercorrelated in a process derived from the use of 
morphologic tables. That is, projections were assessed in pairs in order to 
judge whether, in future, they would reinforce or mutually exclude each 
other or not influence each other to any significant extent. Clusters of 
projections began to emerge. Some projections featured in more than one 
cluster. In all, four distinct clusters or scenarios were developed that differed 
primarily with respect to the “extent of public participation” and “attitude 
towards progress”. The scenarios “progress first”, “scepticism first”, “profit 
first” and “participation first” were described in detail by one subgroup each. 
6. Analysis of implications 
These scenarios describe different frames of reference for the 
commercialisation of biomedicine. The focus of the analysis of implications 
was on the kind of consequences that would result from the realisation of 
these frames. After a process of identifying possible consequences in a 
group discussion, each participant was given the chance to identify his or 
her main positive and negative aspects as a means of evaluating their 
relative importance. Subgroups derived the relevant risks and opportunities 
in more detail. 
7. Recommendations 
The recommendations were aimed at policy. Considering the risks and 
opportunities for each specific scenario, participants worked up a number of 
measures that should be included in policies today in order to foster and 
realise opportunities while minimizing or avoiding risks. Recommendations 
were specified with respect to desirable targets and necessary measures. 
Overall recommendations were not developed due to time constraints. Yet, 
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depending on the difference between the scenarios, this might be a sensible 
step in order to gauge overall priorities and worries. 
Evaluation 
In order to conduct a process evaluation44,45, a questionnaire was administered to all 
participants at the end of each working session in order to gauge participant satisfaction 
and create the ability to adjust the process in real time (closed questions on a 5-point Likert 
scale). This was supported through a series of in-depth interviews during and after the 
meetings in order to elicit information on opinions towards method, content, organisation 
and facilitationf. 
Results 
Scenarios 
Figure 4 below illustrates the twelve key factors identified after the initial three stages 
arranged on a grid according to their active and passive impact. 
-------------------------- 
insert figure 4 about here 
-------------------------- 
These factors formed the basis for projections which, in turn, could be clustered into four 
scenarios. Table 1 summarises the factors, their main projections and how they fitted into 
the scenarios. 
------------------------------- 
insert Table 1 about here 
-------------------------------- 
From this detail, four participant subgroups developed the actual scenarios. We would like 
to stress here, that the research team deliberately did not interfere with the writing of the 
                                              
f Interviews were conducted and analysed by Alexander Görsdorf as part of the empirical work for his ethnographic 
Magister thesis (submitted). 
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final versions in order to arrive at a text as close as possible to participants’ views including 
the use of their own language. This is a key difference to standard scenario procedures. 
Though the research team felt the temptation to revise the final output, the main aim, to 
restructure the scenario method to become a tool for public involvement, remained 
paramountg. 
Therefore, the following results represent the core of the original thoughts of the group 
rather than an analysis on the basis of any particular theoretical framework. Each scenario 
was worked up as a description of the possible state of affairs including key targets (2014) 
and recommendations (now). We present here a translated summary of the original 
scenario descriptions as well as a list of the key targets for each scenario. 
Scenario I: Progress first 
The current political system is the “expertocracy”, i.e. the natural sciences, supported by 
industry and politics, play the key role in decision-making processes. The permissive legal 
framework allows research to proceed almost uninhibited, which makes novel medical 
cures and the individually requested optimisation of the human body possible. Scientific 
breakthroughs and new applications create a positive climate on the job market. Genetic 
testing and the establishment of therapeutic possibilities lead to a devaluation of the status 
of the ill and handicapped. Risk assessments are insufficient and the “generation contract” 
(the basis of the German pension system) has collapsed. A sidelining of the social and 
human sciences within the public discussion and decision-making processes encourages 
the system to proceed further in the same direction. 
Key Targets (2014): 
1. The ability to deal responsibly with new technological possibilities in the biomedical 
field should be retained and fostered. 
                                              
g The original text (in German) can be found at www.bioethik-diskurs.de . 
 13
2. A balance between natural and social/human sciences should be struck in order to 
retain and/or start a critical dialogue. 
3. Acceptance of the ill and handicapped should be preserved and supported. 
4. Retention of the data protection act and the right not to know. 
5. Independent biomedical research should be further supported, albeit with a 
recognition of the importance of a disparity transfer between the federal states of 
Germany (the “Länder”). 
Recommendations (now): 
1. Compulsory risk assessments should receive guaranteed funding within a legal 
framework that strictly applies the causation principle (German equivalent of the 
polluter pays principle). 
2. The natural and social/human sciences should be on equal footing in terms of 
funding for research and teaching as well as staffing of expert commissions. 
3. Equitable policies should be supported and heavily publicised. The integration of 
those concerned in decision-making processes should be ensured. 
4. Legislation has to determine what kind of data can be used for which purposes and 
by whom. No-one should be forced to undergo genetic testing against their will. 
5. Public funding should be particularly encouraged in areas of societal desirability 
that are neglected by industry. 
Scenario II: Scepticism first 
The public and political acceptance for basic and applied biomedical research has been 
lost within a generally sceptical and distanced Germany. Public funding is administered 
according to moral and ethical criteria and the subsequent risk-conscious approach 
prohibits a successful commercialisation through industry and science. Industry is 
confronted with three options: (1) Adaptation with a focus on conventional and alternative 
medicine. (2) Moving abroad with grave economic consequences for Germany. (3) Shifting 
the current regulatory framework through lobbying. 
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Key targets (2014): 
1. Optimisation of the conditions for establishing conventional and alternative 
medicine in Germany. 
2. The move of research and industry abroad has to be avoided. 
3. The preconditions for public debate and opinion formation have to be improved. 
Recommendations (now): 
1. Public funding should support a suitable framework including fundamental 
research, a pro-research societal climate, tax cuts and incentives. 
2. A broad public debate should attempt to replace a diffuse antipathy towards 
biomedicine with a clear determination of the aspects that are not wanted in order 
to create room for action. 
3. Support for interest in schools, critical reflection in higher education and training, 
high quality science journalism, transparency in research and a common dialogue. 
Scenario III: Profit first 
Within an industrial dictatorship, profit, demand and market interests as opposed to politics 
and society determine targets for research and therapies. Consequently, applications that 
are not strictly economically viable are dropped and increasing competition undermines the 
free exchange of research findings not only via patenting. Progress is driven forward 
without second thoughts so that pre-implantation diagnostics, gene therapy and cloning 
have succeeded in eliminating hereditary diseases. Positive economic growth leads to an 
intake of international specialists and an increase in the pace of development. The health 
system has been privatised efficiently and personal income determines cover. Industrial 
funding for higher education leads to early specialisation. 
Key targets (2014): 
1. Economic growth within the biomedical sector. 
2. Avoidance of the privatisation of knowledge and an (inter)nationally inequitable 
distribution of biomedical costs and benefits. 
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Recommendations (now): 
1. Create suitable framework conditions for companies in the biomedical sector. 
2. Biomedical research as well as the production and distribution of therapies should 
be coordinated and supported at an international level. 
Scenario IV: Participation first 
An increase and improvement in the possibilities for participation in political and economic 
decisions has led to a growth in public awareness and knowledge as well as improved 
judgement capabilities. The guiding principles that have come to the fore are the ‘sanctity 
of life’, the ‘right not to know’ and the ‘minimisation of suffering’. On this basis and with 
continuing involvement of citizens, research funding is administered by the state. Under 
these conditions, industry can invest in alternative and conventional medicine, migrate or 
conceive of the difficulties as an opportunity. Particular the third option carries the danger 
that discourses might be manipulated and decisions individualised, neither of which are 
necessarily socially desirable or sustainable. 
Key targets (2014): 
1. Secure, effective and binding discourse including industry. 
2. A demand-led biomedical production should be supported via an efficient co-
ordination of research using public funding directly for research but also as seed-
corn money. 
3. Social security, justice and an adequate standard of living have to form the basic 
pillars of the welfare state. 
4. The migration of the biomedical sector has to be avoided. 
Recommendations (now): 
1. Participatory and supervisory processes should be worked up that create a 
commitment to transparency via ethical certification (such as a consumer 
organisation seal of approval). 
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2. A central role for the social/human sciences in a reform of the education and 
(leadership) training structures and contents should lead to a stronger focus on 
core values in schools, politics and the corporate sector. 
3. The state (research) and industry (application) should share the burden of 
conducting compulsory technology assessments. 
4. Research funding should partly be diverted into a diversity in the alternative medical 
sector. 
Evaluation 
Outcome 
Within the European context, the Centre for Research on Innovation and Competition in 
Manchester, UK46, and the European Environment Agency42 have developed similar 
scenarios. Further, the World Business Council for Sustainable Development presented 
biotechnology scenarios34 and its findings from a stakeholder dialogue on intellectual 
property rights in biotechnology and health care47. These reports are not directly 
comparable as they focus on slightly different topics and use variants of the scenario 
approach. Nevertheless, they offer a possibility to contextualise the current citizen 
scenarios. 
It is clear from the outset, that experts and stakeholders are able to produce outlooks in far 
greater detail using a wealth of technical expertise that will always be beyond any group 
selected from the general public. Intimate knowledge of key factors such as market volume 
and dynamics, product pipelines and their associated costs and benefits, the way different 
products and platform technologies are able to generate value in different sectors of the 
industry as well as insights into the political detail of regulatory and legislatory processes, 
is extremely valuable and out of reach for most non-professionals. 
Yet the basic understanding of the way biotechnology might develop in the next decade or 
so does not differ fundamentally. Though in less detail, economic, political, scientific-
technical and public opinion aspects were all dealt with in the citizen workshops presented 
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in this paper. Whether this lack of detail makes these findings a valuable resource in an 
expert sense of the word remains a moot point. The participants were well aware that they 
could not offer the specific information generated by experts in the field. They were also 
aware, however, that they could contribute something else – a broader view of the societal 
relevance of biotechnology in the context of their own lives. 
The results also showed that the systematic approach of the scenario method led to more 
profound results than a purely open and unstructured discussion would typically have 
achieved. This allowed for the derivation of options for action that were specifically 
matched with the different future opportunities and risks. 
Process 
The analysis of the evaluation questionnaires confirms this positive impression. The 
majority of people agreed that the process had been a valuable experience. The averaged 
results below indicate the level of satisfaction with the method per se. Further data on the 
process itself such as venue, facilitation etc. is not presented in this context. 
-------------------------------- 
Insert Table 2 process evaluation data about here 
--------------------------------- 
Note the lack of support for the method’s rigorous application on which the research team 
insisted to create a methodological baseline from which to begin to develop sensible 
modifications. While the systematic nature of the entire process was valued, participants 
made absolutely clear that the lengthy procedure and the arduousness of the core stages 
were challenging and left room for improvement. Though the systematic approach was 
appreciated, many participants voiced their concern about a lack of time given the 
cognitive tasks they were expected to perform. The long duration of the entire procedure 
was seen as demanding. 
The in-depth interviews revealed that the degree of dissatisfaction may have had less to 
do with the process itself as more with the organisation and running of the event. It 
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appeared that participants were somewhat shocked by the complexity of the process that 
was not sufficiently explained to them at the start of the first meeting. An evaluation of their 
comments suggests that ensuring that everyone knows exactly what this method involves 
and why certain steps are included is vital to reduce cognitive load and dissatisfaction. The 
time demands of the entire process will depend on the intellectual ability and motivation of 
the group. 
A dissatisfaction with the ‘interdependence analysis’ as revealed by the interview data 
raises conceptual questions. Similar to a multi-criteria decision analysis, the cross-impact-
matrix is an attempt to evaluate participants’ views on the basis of their individual 
components without actively considering the bigger picture. As a consequence, 
participants may arrive at a different set of priorities than a more holistic approach may 
have delivered. The research team considered this step useful to encourage participants to 
reflect their own position. With hindsight, the considerable cognitive and time demands of 
this stage might have been more of a hindrance than an addition, particularly if one 
considers a less well educated group of participants. Limiting the number of factors that 
are entered in the matrix appears to be a preferable option. 
This evaluation indicates that the direct transfer of a stage sequence, that proved useful in 
an expert context, onto a group of “lay” participants is not straightforward. Allowing for 
enough time to give people a chance to familiarise themselves with and contemplate each 
step, while, at the same time, keeping the entire procedure transparent, focused and within 
an acceptable overall time limit seems the most important aspect from a participant’s point 
of view. One way of squaring these conflicting demands may be to select more specific 
topics in order to reduce the overall scope of the exercise. 
On the other hand, it is easy to lose the creative mode of thinking when focusing on too 
much detail and sticking too closely to procedure. We felt that the real value of this 
exercise was in exploring the views, understandings and visions of citizens stimulated by 
social interaction and expert consultation. Some structure certainly helps people to get to 
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grips with the subject matter and forces them to engage with a broader range of issues 
and views than they would otherwise deal with. Yet maximising the trade-off between 
somewhat superficial creativity and exploration on the one hand, and detailed work in an 
imposed structure on the other, remains a difficult challenge. The specific balance will 
depend to a large extent on the kind of people sampled. 
We felt that a group of many more than 20 people was probably too large to maintain 
interest throughout the stages. Particular when sampling from a population less well 
educated, a smaller group size of about 12-15 might be more appropriate in order to 
ensure comfortable participation during the different stages. 
Discussion 
The validity of the output as well as the process itself should not only be judged against its 
level of detail or its technical insight. These are expert based criteria that are only partly 
applicable to a citizen-expert forum, which ought to be as much about mutual social 
learning as it is about an insightful debate with an informative output. 
Apart from the usefulness of the scenarios, we see some of the exercise’s real value in its 
potential to create surprises and stimulate further and broader debate in public as well as 
policy circles. We were positively surprised by the complexity of the debate. The fact that 
more than thirty relevant issues were raised in the brainstorming and that those could be 
reduced to twelve key impact factors in a difficult process shows once more that non-
experts are capable of a more detailed and thoughtful contribution than they are often 
given credit for48. From this perspective, we argue that the process has added value to the 
existing debate on biomedicine. 
It also demonstrates that the issue of biomedicine and the economy cannot be judged 
outside a broader societal context. Issues that matter to people, such as education, health 
and the stigmatisation of disease and disability, are as much part of the rich picture 
developed by the participants as the value of a growing economy, the treatment of painful 
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and often life-threatening illness or the importance of the corporate sector in a functioning 
society. 
It is important to note that this broader view of the issue is not caused by a lack of detailed 
knowledge in the relevant aspects in a narrow sense of the word. Instead, it explains why 
many people are often dissatisfied with the specific focus of expert-led debates and their 
outputs. For many it is not about questioning the value of the ability of experts to detach a 
single topic from its societal context and assess the minute and important detail. Rather, it 
is argued that the expert assessment is only one way, if an important one, to view the 
subject matter. Its reintegration into a broader context, as defined by those concerned, is 
equally relevant and deserves significant attention. 
Conclusions 
Overall, the process has been a valuable experience for the participants as well as for the 
experts and the research team. The social learning process encountered over the three 
sessions was remarkable. Though the citizen-expert-interaction needs to be supported and 
takes time to develop, the final outcome is evidence that participants responded well to this 
kind of opportunity. 
Within the limitations indicated above, the structure of the scenario method supports a 
well-founded discussion that builds on participants’ initial knowledge and understanding, 
develops through social interaction and is able to draw on scientific-technical expertise 
without allowing this particular angle to take over from the original focus. Compared to less 
focused interactive methods such as conventional focus groups, the scenario method 
fosters in-depth debate at the expense of open creativity. This has to be kept in mind when 
using this approach at different stages of decision-making processes. 
On part of the participants, the format requires a good deal of time, attentive capacity and 
concentration as well as communicative ability and willingness to engage. Such high task 
performance requirements may be interpreted as being prohibitive for a use of the tool with 
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participants of certain intellectual abilities and motivations. On the other hand, interaction 
with peers leads to a very varied learning environment that might be successful in drawing 
less inclined or able people into the process. Further research will have to investigate 
different structures with different participants in order to optimise the procedure for a 
particular set of circumstances. 
We are confident in recommending that, after a period of methodological optimisation, this 
approach can be integrated into relevant expert-based activities at policy level such as 
horizon scanning or future search conferences. This way, a broad set of public views could 
be included in political debates right from the start – a step that could only help to reduce 
conflict during later stages and implementation. 
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Figure 1 Schematic of generic scenario method 
women
age group 16-25 age group 26-40
high school college employed college/maternity l. employed
3 3 2 3 3
 
Figure 2 Socio-demographic sample selection criteria for women (approx. eq. for men) 
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Table 1 Key Factors and their interpretation within the different scenarios 
 
Progress First Scepticism First Profit First Participation First
Links with 
international 
research 
Links with international 
research (Innovation & 
Globalisation) 
Optimisation of 
man 
 
Scientific Progress 
Changes in 
society 
 
 
Cost reduction via 
preventive 
medicine 
Industry 
determines 
content 
Industry determines 
content 
Research 
regulated via direct 
democratic 
elements 
Freedom of 
research 
“Everything 
goes” – zero 
regulation 
Prohibition of research on the 
human genome 
“Everything goes” – zero 
regulation 
 
Political decision-
making 
“Expertocracy” Polit-oligarchy Economic dictatorship Direct Democracy 
Values toward 
biomedicine 
Treatment of 
untreatable 
illness and 
disease 
 Treatment of untreatable 
illness and disease 
Treatment of 
untreatable illness 
and disease 
Interpretation of 
human dignity 
Identity 
question 
Holiness of life  Holiness of life 
 
    Right not to knowh
 Privately financed health 
service 
National regulation 
and financing of 
the health service 
 Preventive direction Preventive 
direction 
Health regulation 
 
 
Curative direction Curative direction 
University funding Third party 
funding 
Low budget Industry funding – large 
budget 
Public funding 
Economic policy Acceleration of 
progress (state 
is economically 
dependent) 
Public funding according to 
moral-ethical criteria 
State is economically 
dependent and retreats 
Public funding 
according to 
moral-ethical 
criteria 
Education  Alternative school concepts 
(e.g. Waldorf) for everyone 
Privatisation and early 
specialisation 
Broad general 
education 
Demand  Desire: Yes 
Acceptance: 
No 
Funding: Yes 
Desire: Yes
Acceptance: 
No 
Funding: No
  
Acceptance Russian 
Roulette 
Moral dilemma ; all for 
nothing 
Russian Roulette 
and flippancy 
flippancy 
Concept of Illness 
and Disease 
Elevation of 
Health; 
stigmatisation 
of illness; data 
protection 
 Stigmatisation and data 
protection 
 
                                              
h The concept of informational self-determination is prominent in the German bioethical debate, particularly in the 
context of genetic counselling and compulsory genetic testing for insurance purposes. ‘Right not to know’ means 
that a person should not be forced to know something about him- or herself. It is heavily contested as the counter 
argument (a person has a responsibility to know about oneself in order to protect, e.g. family members) perhaps 
carries equal weight. 
 27
Table 2 Process evaluation data based on a questionnaire administered after the last 
event 
 
[n=21] 5 Point Likert Scale 
1=strongly disagree - 3=neutral - 5= strongly agree 
% (std.dev.) 
Overall I think the event has been a success. 3.5 (0.4) 
The scenario method stimulates new thoughts. 3.6 (0.7) 
The scenario method fosters systematic thinking. 3.6 (0.6) 
The scenario method is suitable for “lay” people. 3.5 (0.5) 
I enjoyed the work. 3.7 (0.7) 
The scenario method makes it easier to recognise connections and 
interdependencies. 
3.7 (0.6) 
The structured and sequential approach of the scenario method is an 
advantage. 
3.3 (1.1) 
If you stray from the original structure of the scenario method, it will tell in 
the quality of the output. 
2.5 (0.7) 
Proceeding according to the scenario method can only be seen as a 
guideline. In order to get decent results, deviations from the standard 
procedure have to be tolerated. 
4.1 (0.4) 
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